According to Spero Therapeutics's latest financial reports the company's current earnings (TTM) are S$22.84 M. In 2023 the company made an earning of S$30.56 M an increase over its 2022 earnings that were of -S$57.07 M.The earnings displayed on this page is the company's Pretax Income.